Form 4: Xylem EVP Cho Boosts Stake via Performance Vesting
Executive Compensation Update
Xylem Inc.'s EVP of Strategy, Albert Cho, acquired common stock and stock options through performance-based vesting and restricted stock awards, while also disposing of shares for tax obligations.
Summary
- Albert Cho, EVP, Strategy at Xylem Inc., acquired a total of 3,715 shares of common stock on March 1, 2026, through the vesting of performance-based stock units.
- These units were granted under the Xylem 2011 Omnibus Incentive Plan and vested due to the achievement of performance criteria related to Total Shareholder Return (1,311 shares), Adjusted EBITDA (1,082 shares), Revenue (735 shares), and ESG performance (587 shares).
- An additional 1,042 shares of common stock were awarded as restricted stock units on March 2, 2026, which are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
- Cho also acquired 3,713 non-qualified stock options on March 2, 2026, with an exercise price of $128.98, which will vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029, and expire on March 2, 2036.
- To cover tax liabilities incident to the vesting of various stock units, Cho disposed of a total of 2,276 shares of common stock at a price of $128.98 per share on March 2, 2026.
- Following these transactions, Cho's direct beneficial ownership of common stock increased to 16,588 shares, and he beneficially owns 3,713 non-qualified stock options.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this filing positively as it reflects the achievement of performance targets and ongoing executive incentive alignment, indicating management's continued commitment to the company's long-term success.
Positives
- Vesting of 3,715 shares of common stock indicates the achievement of performance criteria related to Total Shareholder Return, Adjusted EBITDA, Revenue, and ESG performance.
- The award of 1,042 restricted stock units and 3,713 non-qualified stock options demonstrates ongoing incentive alignment with long-term company performance.
- The increase in beneficial ownership of common stock to 16,588 shares (after tax withholdings) reflects a continued stake in the company's success.
Negatives
- Disposition of 2,276 shares of common stock to cover tax liabilities reduces the immediate net increase in direct beneficial ownership from the vested units.
Future Outlook
The filing indicates future vesting schedules for restricted stock units and non-qualified stock options, with increments scheduled for March 1, 2027, March 1, 2028, and March 1, 2029. The non-qualified stock options have an expiration date of March 2, 2036.
Industry Context
StockSavvy.ai notes that executive compensation tied to performance metrics like Total Shareholder Return, Adjusted EBITDA, Revenue, and ESG performance is a common practice in the industrials sector, aligning management incentives with shareholder value creation and sustainability goals. The use of restricted stock units and stock options further reinforces long-term commitment.
Comparison to Industry Standards
- Executive compensation structures involving performance-based stock units, restricted stock units, and stock options are standard practice across large-cap industrial companies, similar to peers like Danaher Corporation (DHR) or Roper Technologies (ROP).
- The inclusion of ESG performance as a vesting criterion for executive compensation aligns Xylem with a growing trend among global companies to integrate sustainability metrics into executive incentives, a practice seen in leaders like Schneider Electric or Siemens.
- The specific vesting schedule of one-third increments over three years for new awards is a common approach to retain executives and ensure long-term alignment, comparable to practices observed in many S&P 500 companies.
Stakeholder Impact
- Shareholders: The vesting of performance-based awards indicates the achievement of company performance metrics (TSR, Adjusted EBITDA, Revenue, ESG), which is generally positive for shareholders. The executive's increased stake aligns interests.
- Employees: The filing pertains to executive compensation and does not directly impact the broader employee base, though incentive plans are common.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this executive compensation filing.
Next Steps
- Vesting of restricted stock units and non-qualified stock options in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
- Expiration of non-qualified stock options on March 2, 2036.
Key Dates
| Date | Description |
|---|---|
| 2016-02-24 | Date the Xylem 2011 Omnibus Incentive Plan was Amended and Restated. |
| 2021-03-01 | Grant date for ESG performance-based stock units. |
| 2023-03-01 | Grant date for performance-based stock units related to Total Shareholder Return, Adjusted EBITDA, and Revenue, and restricted stock units. |
| 2024-03-01 | Grant date for restricted stock units. |
| 2026-03-01 | Transaction date for vesting of performance-based stock units. |
| 2026-03-02 | Transaction date for award of restricted stock units, award of non-qualified stock options, and disposition of shares for tax liability. |
| 2026-03-03 | Signature date of the reporting person. |
| 2027-03-01 | First vesting increment date for restricted stock units and non-qualified stock options awarded on March 2, 2026. |
| 2028-03-01 | Second vesting increment date for restricted stock units and non-qualified stock options awarded on March 2, 2026. |
| 2029-03-01 | Third vesting increment date for restricted stock units and non-qualified stock options awarded on March 2, 2026. |
| 2036-03-02 | Expiration date for non-qualified stock options awarded on March 2, 2026. |
Recommendation
holdThis Form 4 filing details routine executive compensation transactions, including the vesting of performance-based awards and new grants, along with tax-related dispositions. While the achievement of performance metrics is positive, these are expected events and do not provide new fundamental information that would significantly alter the investment thesis for Xylem Inc. Therefore, a "hold" recommendation is appropriate as the filing confirms ongoing executive alignment without introducing new catalysts for a "buy" or "sell" decision.
Keywords
Xylem Inc., XYL, Albert Cho, Form 4, insider trading, beneficial ownership, stock options, restricted stock units, performance-based compensation, executive compensation, Total Shareholder Return, Adjusted EBITDA, Revenue, ESG performance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.